Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia
- Resource Type
- Article
- Source
- In
Atherosclerosis 2001 157(1):137-144 - Subject
- Language
- ISSN
- 0021-9150